Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined With Erythropoietin Can Improve Acute Spinal Cord Injury

Human Brain–Derived Neurotrophic Factor Gene-Modified Bone Marrow Mesenchymal Stem Cells Combined With Erythropoietin Can Improve Acute Spinal Cord Injury

Objective: To assess the effect as well as mechanism of bone marrow mesenchymal stem cells (BMSCs) modified by the human brain–derived neurotrophic factor gene combined with erythropoietin (EPO) in the treatment of acute spinal cord injury (SCI) in rats. Methods: The Brain-derived neurotrophic facto...

Full description

Bibliographic Details
Main Authors: YongLei Li, Hongchen Wang, Xiaofang Ding, Jiancheng Shen, Haitao Zhou, Dengxue Jiang, Chen Jin, Kuang Li
Format: Article
Language:English
Published: SAGE Publishing 2020-03-01
Series:Dose-Response
Online Access:https://doi.org/10.1177/1559325820910930

Similar Items

Similar Items